On 28th March 2017, the Biosport project team, in conjunction with Professor Ilyas Khan (Swansea University) are bringing together leading scholars, clinicians and practioners in sports medicine along with biotechnology company representatives, medical insurers and trade union reps to discuss and debate the use of innovative and biological therapies in treating sports injuries.
The day will be divided between paper presentations and open discussion sessions around 4 themes:
1. The Biosport project: overview of objectives and findings
2. Orthobiologics: market, science and clinical applications
3. Case studies in injury treatment from professional football and cycling
4. Ethical and welfare issues
Participants include:
Francesco dell'Accio, Queen Mary University
Lars Engbretson, IOC Commission
Vincent Gouttebarge, FIFPro
Paul Anderson, Orthocell
Shaabaz Mughal, Totteham Hotspurs Football Club
Helen Millson, Physiotherapist and medical insurer
Nigel Hawkins, HCA healthcare UK
Summary of discussion (coming soon)
Points for debate (coming soon)
